Eli Lilly & Co.
LLY
NYSE
IPO1970
about LLY
Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells a wide range of human healthcare products, with a strong focus on therapeutic areas like diabetes, obesity, immunology, oncology, and neuroscience.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $1029.11 | $1029.69 | $1004.14 | $930.4B | 3.30M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$6.22 | 61.56 | 52.28 | 41.09% | 31.72% | 0.68% |
